Walgreens Boots Alliance and AmerisourceBergen shares dropped on Tuesday after a report said the two companies had wrapped up discussions about a possible acquisition without reaching a deal.

Shares of Walgreens, the global drugstore group, were down 2.6 per cent to $68.73, while AmerisourceBerger, the pharmaceuticals distributor, shed 5.5 per cent to $95.01 on the heels of the report from CNBC.

Earlier this month, Walgreens was said to be discussing a purchase of AmerisourceBergen, amid big shifts in the pharmacy and drug distribution industry in the US. Sources familiar with the discussions told the FT that the two companies had been talking for several weeks about a potential deal, which would combine the second-largest US drugstore chain with one of the country’s largest medicines distributors.

CNBC said on Tuesday that the early-stage exploration had ended without an agreement, but that it was possible that talks could one day resume.

Walgreens already owns 26 per cent of Amerisource.

Get alerts on AmerisourceBergen Corp when a new story is published

Copyright The Financial Times Limited 2019. All rights reserved.
Reuse this content (opens in new window)

Comments have not been enabled for this article.

Follow the topics in this article